REFERENCES
- Andersson, L. 1965. Combined prophylaxis of haemorrhage and thrombosis after prostatectomy. Acta chir. scand. 130, 393–398.
- Back, N. & Steger, B. 1968. Effect of inhibitors on kinin-releasing activity of proteases. Fed. Proc. 27, 96–99.
- Beller, F. K., Mitchell, P. S. & Gorstein, F. 1967. Fibrin deposition in the rabbit kidney produced by protease inhibitors. Thrombos. Diathes. haemorrh. (Stuttg.) 17, 427–439.
- Diwok, K., Guelzow, M. & Trettin, H. J. 1965. Die Wirkung der Epsilon Aminokapronsäure auf die experimentelle Pankreatitis der Ratte. Z. ges. inn. Med. 20, 111–112.
- Frey, E. K., Kraut, H. & Werle, E. (eds.). 1968. Das Kallikrein-Kinin-System und seine Inhibitoren. Ferdinand Enke, Stuttgart.
- Fritz, H., Brey, B., Schmal, A. & Werle, E. 1969. The common identity of progressive antikallikrein and alpha-1-antitrypsin of human serum. Hoppe-Seylers Z. physiol. Chem. 350, 1551–1555.
- Gabryelewicz, A., Niewiarowski, S., Prokopowicz, J. & Chlebowski, J. 1969. Heparin and protease inhibitors in the prevention of experimental acute pancreatic necrosis in dogs. Digestion 2, 7–16.
- Gormsen, J. & Josephsen, P. 1967. The effect of Trasylol on blood coagulation after intravenous injection. Thrombos. Diathes. haemorrh. (Stuttg.) 17, 51–57.
- Hamberg, U. 1968. Plasma protease and kinin release with special reference to plasmin. Ann. N. Y. Acad. Sci. 146, 517–526.
- Karawanow, A. G. & Ossipgolz, S. L. 1966. The use of epsilon-aminocaproic acid in the treatment of acute pancreatitis. (In Russian). Klin. Med. (Moskva) 44, 13–15.
- Konttinen, Y. P. 1968. Fibrinolysis: Chemistry, Physiology, Pathology and Clinics. Oy Star Ab, Tampere, Finland, pp. 156–157 and 343–360.
- Lancet 1969. 2, 830–831. Vascular factors in acute pancreatitis.
- Lippmann, W. & Wishnick, M. 1965. Effects of the administration of epsilon amino caproic acid on catecholamine and serotonin levels in the rat and dog. J. Pharmacol, exp. Ther. 150, 196–202.
- Lundh, B., Laurell, A. B., Wetterqvist, H., White, T. & Granerus, G. 1968. A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism. Clin, exp. Immunol. 3, 733–745.
- Markwardt, F., Kloecking, H. P. & Landmann, H. 1966. Vergleichende Untersuchungen ueber Antifibrinolytika. Thrombos. Diathes. haemorrh. (Stuttg.) 15, 561–569.
- Niewiarowski, S. & Wolosowicz, N. 1966. The in-vivo effect of epsilon-aminocaproic acid (EACA) on human plasma fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg.) 15, 491–499.
- Nordström, S., Blombäck, B., Blombäck, M., Olsson, P. & Zetterqvist, E. 1968. Experimental investigations on the antithromboplastic and antifibrinolytic activity of Trasylol. Ann. N. Y. Acad. Sci. 146, 701–714.
- Ratnoff, O. D. 1969. Epsilon aminocaproic acid — a dangerous weapon. New Engl. J. Med. 280, 1124–1125.
- Toskin, K. D., Tepper, P. A. & Prozenko, W. A. 1968. Behandlung der akuten Pankreatitis mit dem Antifibrinolytikum PAMBA. Z. ges. inn. Med. 23, 800–803.
- Wright, P. W. & Goodhead, B. 1970. Prevention of haemorrhagic pancreatitis with fibrinolysin or heparin. Arch. Surg. 100, 42–46.